The Irritable Bowel Syndrome (IBS) is a gastrointestinal disorder associated with abdominal pain, change in bowel habitat, recurrent/remitting behaviour. Like IBD, this syndrome is associated with: altered gut-brain axis, abnormal microbiota and persistent alteration of the immune system. Recent studies show that patients with IBD have a microbiota different from that of healthy subjects with the greater presence of some microbial species rather than others. In particular, Sokol et al (2016) showed that in patients with IBD some fungal species (Ascomycetes, especially Saccharomyces cerevisiae) decrease in percentage compared to healthy subjects, while others increase (Basidiomycetes, particularly Mallasezia sympodialis). Furthermore, in the sick subjects, the species of genus Candida increase in as a percentage even if they do not cause infectious diseases. Our preliminary data show that faecal samples from patients with IBS are characterized by fungal strains belonging to the genus Candida. These are more active than the same strains found in healthy subjects, while not causing infectious diseases.

Di Vito, M., Bellardi, M.G., Sanguinetti, M., Palucci, I., Modesto, M., Togni, H.D., et al. (2017). Activity of essential oils and hydrolates on both microbial strains isolated from patients with IBS and probiotics. In vitro study.

Activity of essential oils and hydrolates on both microbial strains isolated from patients with IBS and probiotics. In vitro study

DI VITO, MAURA;BELLARDI, MARIA GRAZIA;MODESTO, MONICA MARIANNA;MATTARELLI, PAOLA
2017

Abstract

The Irritable Bowel Syndrome (IBS) is a gastrointestinal disorder associated with abdominal pain, change in bowel habitat, recurrent/remitting behaviour. Like IBD, this syndrome is associated with: altered gut-brain axis, abnormal microbiota and persistent alteration of the immune system. Recent studies show that patients with IBD have a microbiota different from that of healthy subjects with the greater presence of some microbial species rather than others. In particular, Sokol et al (2016) showed that in patients with IBD some fungal species (Ascomycetes, especially Saccharomyces cerevisiae) decrease in percentage compared to healthy subjects, while others increase (Basidiomycetes, particularly Mallasezia sympodialis). Furthermore, in the sick subjects, the species of genus Candida increase in as a percentage even if they do not cause infectious diseases. Our preliminary data show that faecal samples from patients with IBS are characterized by fungal strains belonging to the genus Candida. These are more active than the same strains found in healthy subjects, while not causing infectious diseases.
2017
Microbiota: a continuum from insects to primates
Di Vito, M., Bellardi, M.G., Sanguinetti, M., Palucci, I., Modesto, M., Togni, H.D., et al. (2017). Activity of essential oils and hydrolates on both microbial strains isolated from patients with IBS and probiotics. In vitro study.
Di Vito, Maura; Bellardi, Maria Grazia; Sanguinetti, Maurizio; Palucci, Ivana; Modesto, Monica; Togni, Heide De; Bugli, Francesca; Mattarelli, Paola...espandi
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/603711
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact